Delivery Order SPE2DB24D2003-SPE2DB25FXHR6

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $1,360.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,571.14, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML medication. It is a firm-fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The fixed-price delivery order has a ceiling value of $6,291.37 and an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $13,351.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of July 24, 2024. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $2,882.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through April 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $10,052.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of April 18, 2025. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,984.38 and is a delivery order with a firm fixed price. It is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $3,097.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of January 24, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $8,030.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of April 10, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,811.91, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of December 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHR6
    Delivery Order

This federal contract award, with a ceiling value of $9,578.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This is a firm fixed-price delivery order contract, with an ultimate completion date of May 14, 2025. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/12/25, 11:54 AM